COVID-19: Delay of third jab for extremely vulnerable
Studies have shown that people who are immunosuppressed - around [...]
ESMO 2021: Cancer and COVID-19: Outcomes and risk factors
This year there was some very important data presented at [...]
ESMO 2021: COVID-19 vaccine in cancer patients is comparable to the general population
The latest findings from five studies presented at the ESMO [...]
Shielding programme ends for the most vulnerable
Following expert clinical advice, the government is ending the requirement [...]
Immunotherapy and COVID-19 in cancer patients
A recent review published in the Journal for ImmunoTherapy of [...]
Open letter from cancer charities to the public
Forty (40) charities and organisations have written an open letter, [...]
Most vulnerable people could be offered a COVID vaccine booster in September
The Joint Committee on Vaccination and immunisation (JVCI) have given [...]
Information about COVID-19 vaccines from the ABPI
The pharmaceutical industry is dedicated to developing effective vaccines that [...]
UK regulator confirms benefits of AstraZeneca vaccine far outweigh the risks
Following suspensions by some countries of the COVID-19 Oxford AstraZeneca [...]
NHS patients could be offered intravenous cancer treatments at home
In an attempt to reduce treatment backlogs and hospital visits, [...]
